As per the report published by Allied Market Research, the global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.
Key Takeaways:
Asia-Pacific region is also anticipated to manifest the fastest CAGR of 14.7% from 2019 to 2026.
MenACWY vaccines segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Request Sample Report at:
https://www.alliedmarketresearch.com/request-sample/330
Covid-19 scenario:
The global lockdown has paused the immunization programs. However, in certain regions the program schedules would be changed. In addition, the R&D processes for vaccine technology have come to a halt. Moreover, in a Covid-19 trial conducted by the University of Oxford, meningococcal medicine has been used as a placebo effect.
Market Segmentation:
Vaccine Type:
- Quadrivalent Meningococcal Vaccines:
- MenACWY Polysaccharide Vaccines
- MenACWY (A, C, W, Y) Conjugate Vaccines
2. Bivalent Meningococcal Vaccines:
- MenB (B, serogroup B)
- Protein-Based Vaccines
3. Patient Age Group:
- Patient Age Group:
- Pediatric Meningococcal Vaccines
- Adolescent and Adult Meningococcal Vaccines:
- Adolescents, Adults, High-Risk Populations,
- Disease Serogroup: Serogroup A Serogroup B Serogroup C Serogroup W Serogroup Y
Geographic Region:
- North America (U.S., Canada, Mexico)
- Europe (UK, Germany, France, the Netherlands, Spain, Rest of Europe)
- Asia Pacific (China, Australia, Rest of Asia-Pacific)
- LAMEA (Latin America, Middle-East, Africa)
Key Benefits For Stakeholders:
- The meningococcal vaccine market share and analysis is based on a comprehensive analysis of key developments in the industry.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
- The study provides an in-depth analysis of the meningococcal vaccine market trends to elucidate the imminent investment pockets.
- The global meningococcal vaccine market trends are studied from 2018 to 2026.
- Information about key drivers, restrains, and opportunities and their impact analysis on the meningococcal vaccine market size is provided.
- Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
- The quantitative analysis of the global meningococcal vaccine market from 2019 to 2026 is provided to determine the market potential.
Based on region, North America accounted for the highest share, holding nearly half of the total share in 2018, and is estimated to maintain its dominant share during the forecast period. On the other hand, the Asia-Pacific region is also anticipated to manifest the fastest CAGR of 14.7% from 2019 to 2026. The market also analyses regions including Europe, North America, and LAMEA.
For Purchase Enquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/330
The key market players analyzed in the report involves Chongqing Zhifei Biological Products Co., Ltd., GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd, Walvax Biotechnology Co., Ltd., Bio-Manguinhos, and Bio-Med Pvt. Limited.
Similar Reports:
Syringes Market https://www.alliedmarketresearch.com/syringes-market-A07514
U.S. Neurovascular Devices Market https://www.alliedmarketresearch.com/us-neurovascular-devices-market-A08685
Clinical Trial Imaging Services Market https://www.alliedmarketresearch.com/clinical-trial-imaging-services-market-A09463
Smoke Evacuation Systems Market https://www.alliedmarketresearch.com/smoke-evacuation-systems-market-A10370
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.